ASCEND BY NTHRYS
Research Abroad Products

Medical Biotechnology Project Topics

Browse all focused areas across all project categories under this field.

Showing 229–240 of 250 project topics
Labeling and Claims Verification Software for IVD Products
A regulatory content management system that ensures IVD labeling, marketing claims, and instructions-for-use comply with region-specific requirements and scientific evidence standards. This prevents costly market recalls and regulatory actions while enabling manufacturers to scale global product labeling across 100+ SKUs simultaneously.
In Vitro Diagnostics Regulatory Compliance Click to view more details →
Real-World Performance Monitoring Analytics for Commercialized IVD Tests
A data analytics platform that aggregates post-market clinical performance data from laboratories and hospitals to demonstrate ongoing IVD safety and effectiveness in real-world settings. This enables manufacturers to build competitive advantages through evidence-backed performance claims and unlock reimbursement improvements worth 15-25% margin increases.
In Vitro Diagnostics Regulatory Compliance Click to view more details →
Plasma Proteomics for Disease Biomarker Discovery
Applying data-independent acquisition mass spectrometry to deeply profile plasma proteomes in disease and control cohorts for discovering novel circulating protein disease biomarkers.
Proteomics-Based Biomarker Discovery Click to view more details →
Proximity Extension Assay for Multiplex Protein Quantification
Using Olink proximity extension assay technology for simultaneous quantification of hundreds of plasma proteins in clinical samples for high-throughput biomarker discovery and validation.
Proteomics-Based Biomarker Discovery Click to view more details →
Tissue Biomarker Discovery by Imaging Mass Spectrometry
Applying MALDI and DESI imaging mass spectrometry for spatially resolved protein and metabolite profiling in tissue sections for identifying disease biomarkers with tissue localization.
Proteomics-Based Biomarker Discovery Click to view more details →
Aptamer-Based Protein Biomarker Measurement
Using SomaScan aptamer array technology for multiplexed quantification of thousands of proteins in biological samples for comprehensive biomarker discovery in clinical proteomics.
Proteomics-Based Biomarker Discovery Click to view more details →
Cerebrospinal Fluid Proteomics Platform for Neurological Disorder Detection
A SaaS-based platform that analyzes CSF protein signatures using high-throughput mass spectrometry to identify biomarkers for Alzheimer''s, Parkinson''s, and other neurodegenerative diseases. This enables diagnostic companies and research institutions to commercialize precision neurology tests with faster turnaround times and improved clinical accuracy.
Proteomics-Based Biomarker Discovery Click to view more details →
Serum Exosome Protein Analysis for Cancer Early Detection
A commercial diagnostic tool that extracts and profiles protein cargo from circulating exosomes to identify cancer biomarkers in blood samples before clinical symptoms appear. This platform generates revenue through licensing agreements with oncology labs and direct-to-consumer cancer screening partnerships.
Proteomics-Based Biomarker Discovery Click to view more details →
Post-Translational Modification Mapping Service for Drug Target Validation
An industry service that uses advanced proteomics to comprehensively map phosphorylation, glycosylation, and ubiquitination patterns on therapeutic targets and diseased tissues. Pharmaceutical companies leverage this data to validate drug mechanisms, reduce development costs, and improve clinical trial success rates.
Proteomics-Based Biomarker Discovery Click to view more details →
Multiplexed Immunoaffinity Enrichment Platform for Rare Protein Biomarkers
A commercial reagent and software platform that uses high-density antibody arrays to isolate and quantify ultra-low abundance proteins from complex biological matrices. This tool enables clinical diagnostics companies to develop breakthrough tests for rare diseases and hidden disease states with minimal sample volumes.
Proteomics-Based Biomarker Discovery Click to view more details →
Longitudinal Proteomics Profiling Service for Precision Medicine Cohorts
A managed service that performs serial proteomics profiling on patient cohorts to identify dynamic protein biomarkers predictive of treatment response and disease progression. This generates recurring revenue through partnerships with healthcare systems and biopharmaceutical companies conducting real-world evidence studies.
Proteomics-Based Biomarker Discovery Click to view more details →
Organ-Specific Proteome Database and Biomarker Discovery Software Suite
A comprehensive SaaS platform offering curated tissue proteome databases with AI-powered tools to identify organ-enriched protein biomarkers for disease diagnostics and drug development. This subscription-based solution monetizes through tiered access for academic researchers, biotech firms, and diagnostic manufacturers seeking competitive biomarker intelligence.
Proteomics-Based Biomarker Discovery Click to view more details →